Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up.
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA. Larsen TL, et al. Among authors: torfoss d. J Thromb Haemost. 2022 May;20(5):1166-1181. doi: 10.1111/jth.15666. Epub 2022 Feb 20. J Thromb Haemost. 2022. PMID: 35114046 Free article. Clinical Trial.
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply.
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA. Larsen TL, et al. Among authors: torfoss d. J Thromb Haemost. 2022 Aug;20(8):1937-1939. doi: 10.1111/jth.15774. J Thromb Haemost. 2022. PMID: 35859282 Free article. No abstract available.
Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.
Torfoss D, Høiby EA, Tangen JM, Holte H, Bø K, Meyer P, Grøttum K, Weyde K, Lauritzsen GF, Sandstad B, Jacobsen AB, Olsen H, Kvaløy S. Torfoss D, et al. J Antimicrob Chemother. 2007 Apr;59(4):711-7. doi: 10.1093/jac/dkm003. Epub 2007 Feb 27. J Antimicrob Chemother. 2007. PMID: 17327294 Clinical Trial.
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily.
Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S. Torfoss D, et al. Scand J Immunol. 2011 Dec;74(6):632-9. doi: 10.1111/j.1365-3083.2011.02618.x. Scand J Immunol. 2011. PMID: 21883353 Free article. Clinical Trial.
Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial.
Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S. Torfoss D, et al. Clin Microbiol Infect. 2017 Mar;23(3):179-187. doi: 10.1016/j.cmi.2016.10.019. Epub 2016 Oct 26. Clin Microbiol Infect. 2017. PMID: 27793737 Free article. Clinical Trial.
Carbapenems and febrile neutropenia - author's reply.
Torfoss D. Torfoss D. Clin Microbiol Infect. 2017 Mar;23(3):214. doi: 10.1016/j.cmi.2016.12.019. Epub 2016 Dec 23. Clin Microbiol Infect. 2017. PMID: 28025133 Free article. No abstract available.
23 results